Clinical Trial

Leukemia Stem Cell-based Assay to Predict Relapse and Survival in Patients With Acute Myeloid Leukemia

Study acronym: MLL-LSC
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to learn about the predict value of leukemia stem cell for acute myeloid leukemia patients with MLL-rearrangement. The main question it aims to answer is: • Could be leukemia stem cell used for relapse prediction in acute myeloid leukemia patients with MLL-rearrangement? Leukemia stem cell will be detected at the same time for participants who detected minimal residual disease using bone marrow as part of their regular medical care to answer the question.
Trial Details
NCT Number NCT07537738
Lead Sponsor Peking University People's Hospital
Conditions Acute Myeloid Leukemia (AML), MLL Rearrangement
Enrollment 210 participants
Start Date 2025-06-01
Primary Completion 2026-04-07 (estimated)
Study Completion 2026-04-07 (estimated)
Updated on ClinicalTrials.gov 2026-04-17